HbA1c variability in adults with type 1 diabetes on continuous subcutaneous insulin infusion (CSII) therapy compared to multiple daily injection (MDI) treatment

OBJECTIVE: To determine if continuous subcutaneous insulin infusion (CSII) therapy is associated with lower glycated haemoglobin (HbA1c) variability (long-term glycaemic variability; GV) relative to multiple daily injection (MDI) treatment in adults with type 1 diabetes mellitus (T1DM). DESIGN: Retr...

Descripción completa

Detalles Bibliográficos
Autores principales: Scott, Emma S, McGrath, Rachel T, Januszewski, Andrzej S, Calandro, Daniel, Hardikar, Anandwardhan A, O'Neal, David N, Fulcher, Gregory, Jenkins, Alicia J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2019
Materias:
Diabetes and Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6937034/
https://www.ncbi.nlm.nih.gov/pubmed/31888933
http://dx.doi.org/10.1136/bmjopen-2019-033059

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6937034/
https://www.ncbi.nlm.nih.gov/pubmed/31888933
http://dx.doi.org/10.1136/bmjopen-2019-033059

Ejemplares similares